Markets

Insider Trading

Hedge Funds

Retirement

Opinion

9 Most Active Stocks to Buy According to Wall Street Analysts

In this article, we will take a look at the 9 Most Active Stocks to Buy According to Wall Street Analysts.

In recent weeks, the Dow Jones, Nasdaq Composite, and S&P 500 have all soared to all-time highs. At the same time, the prospect of the Federal Reserve restarting its rate-easing cycle at its meeting in less than two weeks has investors thrilled. That being said, it is easy to become afraid of such heights when stock market indexes are hovering around all-time highs.

A deteriorating labor market seems to be one growing threat to the market’s progress. The Bureau of Labor Statistics said on September 5 that the United States added only 22,000 jobs in August, extending a four-month period of weak job growth. The news caused equities to drop the same day, amid a minor increase in the unemployment rate.

Reducing inflation to 2% has also been challenging, and tariffs pose a threat to rising consumer costs. This has stopped the rate-cutting cycle this year, though the Fed is expected to lower its benchmark rate at its September meeting.

With that in mind, we will now go over some of the most active stocks to buy according to Wall Street analysts.

Our Methodology

For this list, we utilized stock screeners to list down stocks with an average volume surpassing 2 million. We then selected the stocks with an upside potential of over 20%. These stocks are ranked in ascending order based on their average share price upside potential. Additionally, we have mentioned the hedge fund sentiment around each stock, as of Q2 2025.

Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 373.4% since May 2014, beating its benchmark by 218 percentage points (see more details here).

9. Lululemon Athletica Inc. (NASDAQ:LULU)

Avg Volume: 3.94 million

Analyst Upside: 21.56%

Number of Hedge Fund Holders: 55

Lululemon Athletica Inc. (NASDAQ:LULU) ranks among the most active stocks to buy according to Wall Street analysts. On September 5, TD Cowen reduced its price target on Lululemon Athletica Inc. (NASDAQ:LULU) to $220 from $298, retaining a Buy rating on the sports clothing retailer’s shares. The firm made the change after finding that 66% of Lululemon’s e-commerce orders in the United States are completed via Canada, making use of the de minimis loophole, which the Trump administration recently closed.

This proportion, according to TD Cowen, is “far higher” than expected and gave Lululemon Athletica Inc. (NASDAQ:LULU) a large financial boost of roughly 250 basis points of “unsustainable annual benefit to gross margin.”

According to the firm, Lululemon Athletica Inc. (NASDAQ:LULU) had clear financial incentives to fulfill orders from Canada under the old regulations, even though the company still retains “ample distribution center and ship from store capacity” in the United States.

Lululemon Athletica Inc. (NASDAQ:LULU), a Canadian athleisure company founded in 1998, designs, develops, and distributes a variety of sportswear, accessories, and footwear.

8. Applied Materials, Inc. (NASDAQ:AMAT)

Avg Volume: 7.15 million 

Analyst Upside: 21.66%

Number of Hedge Fund Holders: 81

Applied Materials, Inc. (NASDAQ:AMAT) ranks among the most active stocks to buy according to Wall Street analysts. Cantor Fitzgerald reaffirmed its Overweight rating and $200 price target for Applied Materials, Inc. (NASDAQ:AMAT) on August 25. After Applied Materials’ recent disappointing report, which contrasted with conflicting signals from other semiconductor equipment makers over the July earnings season, the firm responded to investor inquiries regarding possible changes in the industry.

Instead of a fundamental change in the semiconductor equipment industry, Cantor Fitzgerald blamed Applied Materials’ poor performance on “poor internal modeling” and a failure to “set investor expectations appropriately.”

Looking ahead, Cantor Fitzgerald anticipates that remarks made during the next conference season will support its forecast that modest growth in wafer fabrication equipment (WFE) will reach $115 billion in 2026, an increase of around 7%.

Applied Materials, Inc. (NASDAQ:AMAT) provides production equipment, software, and services to the semiconductor industry. The company operates in three segments: Semiconductor Systems, Applied Global Services, and Display & Adjacent Markets.

7. DoorDash, Inc. (NASDAQ:DASH)

Avg Volume: 3.60 million

Analyst Upside: 23.93%

Number of Hedge Fund Holders: 100

DoorDash, Inc. (NASDAQ:DASH) ranks among the most active stocks to buy according to Wall Street analysts. With a price target of $335, Citizens JMP reaffirmed its Market Outperform rating for DoorDash, Inc. (NASDAQ:DASH) on August 25. The firm emphasized the potential impact of autonomous delivery technologies on its operations while retaining its optimistic view of the food delivery platform.

JMP stated that “Autonomy could significantly lower the variable cost of delivery, which would likely further accelerate adoption for DoorDash.”

In another vein, the European Union is expected to examine DoorDash’s $3.9 billion acquisition of Deliveroo through its streamlined merger process. Deliveroo is worth about 2.9 billion pounds as a result of this acquisition, which marks an important milestone in the meal delivery industry.

One of the largest online food delivery companies in the United States, DoorDash, Inc. (NASDAQ:DASH) operates a delivery platform based in San Francisco, California. Historically, the company has categorized itself into five business segments: platform services, advertising, non-restaurant services, international restaurants, and US restaurants.

6. Eli Lilly & Company (NYSE:LLY)

Avg Volume: 4.37 million

Analyst Upside: 24.42%

Number of Hedge Fund Holders: 119

Eli Lilly & Company (NYSE:LLY) ranks among the most active stocks to buy according to Wall Street analysts. Following favorable Phase 3 trial findings for Eli Lilly & Company (NYSE:LLY)’s obesity treatment, UBS reaffirmed its Buy rating and $895 price target on the company on August 27. The pharmaceutical company revealed topline results from its ATTAIN-2 trial examining orforglipron in individuals with obesity and type 2 diabetes.

According to UBS, the data is “a clear positive,” with orforglipron demonstrating efficacy in the same patient population that is comparable to rival Novo Nordisk’s Wegovy. According to the bank, the findings support the clinical profile of orforglipron in the treatment of obesity and point to a “more optimistic commercial outlook” than investors had anticipated in the wake of the previous ATTAIN-1 results.

Based on current market consensus, UBS retains a peak sales forecast of $15 billion for the medication while it awaits full data presentation at the European Association for the Study of Diabetes (EASD) for comprehensive safety and efficacy information.

Eli Lilly & Company (NYSE:LLY) is a major global pharmaceutical company that develops, manufactures, and distributes a wide range of drugs. Founded in 1876, it has grown to become one of the world’s largest pharmaceutical companies.

5. SentinelOne, Inc. (NYSE:S)

Avg Volume: 7.35 million

Analyst Upside: 24.51%

Number of Hedge Fund Holders: 45

SentinelOne, Inc. (NYSE:S) ranks among the most active stocks to buy according to Wall Street analysts. On August 29, DA Davidson boosted SentinelOne, Inc. (NYSE:S)’s price target to $19 from $17, reiterating a Neutral rating on the company’s stock. The target hike comes after SentinelOne’s quarterly results, which revealed Annual Recurring Revenue (ARR) of $1.001 billion, beating average projections of $985 million and indicating a 24% year-over-year gain.

That said, SentinelOne’s fiscal year 2026 revenue guidance was only boosted by $1.5 million at the midpoint mark, despite the company’s good performance metrics. The company’s management attributed this to a cautious attitude considering macroeconomic conditions and contract timing risks.

At the midpoint, the company also reduced its operating margin expectation by about 50 basis points, which management ascribed to the effects of foreign exchange and the Prompt Security acquisition.

SentinelOne, Inc. (NYSE:S) is a well-known cybersecurity company that provides a variety of technologies, including the Singularity Platform, endpoint protection, and attack surface management tools.

4. Constellation Brands, Inc. (NYSE:STZ)

Avg Volume: 2.32 million

Analyst Upside: 30.99%

Number of Hedge Fund Holders: 42

Constellation Brands, Inc. (NYSE:STZ) ranks among the most active stocks to buy according to Wall Street analysts. On September 3, Jefferies decreased Constellation Brands, Inc. (NYSE:STZ)’s price target to $179 from $205, keeping a Buy rating on the company’s shares. The decrease comes after Jefferies cited ongoing issues in the Hispanic consumer category that have become more substantial than expected.

Jefferies pointed out that the beer picture has worsened, resulting in a 10% decrease in the company’s fiscal 2026 EPS estimate, even though Constellation Brands, Inc. (NYSE:STZ) reaffirmed its fiscal 2026 projection in the first quarter following a reset.

Although the firm believes an inflection in fiscal 2026 seems improbable, it added that expectations are now lower with simpler comparisons ahead and what it deems a cheap multiple of 12.5x earnings.

Constellation Brands, Inc. (NYSE:STZ) is a leading manufacturer and marketer of beer, wine, and spirits, best known for its portfolio of premium imported beer brands including Corona Extra, Modelo Especial, and the Modelo Cheladas line.

3. PG&E Corporation (NYSE:PCG)

Avg Volume: 28.24 million

Analyst Upside: 33.00%

Number of Hedge Fund Holders: 77

PG&E Corporation (NYSE:PCG) ranks among the most active stocks to buy according to Wall Street analysts. UBS maintained its Neutral rating and $19 price target for PG&E Corporation (NYSE:PCG) on August 29, following a California Public Utility Commission (CPUC) ruling on the utility’s capital cost restrictions. The CPUC boosted PG&E’s capital cost limitations for energization spending by $1.47 billion beyond previously permitted levels, although the increase was below what was requested in the decision.

UBS does not believe PG&E Corporation (NYSE:PCG) will have to issue more shares to finance the greater spending authorization, even with the higher capital cost constraints.

The firm is waiting on more guidance from PG&E and is keeping an eye on future wildfire and ratebase securitization legislation, given that the California legislative session is slated to end on September 12.

PG&E Corporation (NYSE:PCG), through its subsidiary Pacific Gas & Electric Company, serves over 16 million persons in Northern and Central California.

2. Keurig Dr Pepper Inc. (NASDAQ:KDP)

Avg Volume: 12.96 million

Analyst Upside: 33.33%

Number of Hedge Fund Holders: 46

Keurig Dr Pepper Inc. (NASDAQ:KDP) ranks among the most active stocks to buy according to Wall Street analysts. On August 27, UBS reduced Keurig Dr Pepper Inc. (NASDAQ:KDP)’s price target to $35 from $40, while retaining a Buy rating on the company’s shares, following the the beverage manufacturer’s announcement of plans to purchase JDE Peet’s.

UBS stated that the acquisition has led to confusion about the company’s catalyst path at a point where investors had grown bullish over enhanced top and bottom line visibility, while also increasing execution risk and driving leverage over 5x following the transaction.

Despite these reservations, UBS argued the market’s response seemed disproportionate, stating that the strategic justification for splitting the businesses makes sense and that the transaction’s robust first-year accretion and possible sum-of-the-parts upside are being disregarded.

Keurig Dr Pepper Inc. (NASDAQ:KDP), a 2018 merger, comprises well-known brands such as Dr Pepper, Canada Dry, Snapple, Keurig single-serve coffee pods, and Ghost energy drinks.

1. The Trade Desk, Inc. (NASDAQ:TTD)

Avg Volume: 13.65 million

Analyst Upside: 43.12%

Number of Hedge Fund Holders: 60

The Trade Desk, Inc. (NASDAQ:TTD) ranks among the most active stocks to buy according to Wall Street analysts. Stifel maintained its Buy rating and $90 price target for The Trade Desk, Inc. (NASDAQ:TTD) on August 28 after meeting company officials at Stifel’s 2025 Tech Executive Summit in Deer Valley. Key subjects for discussion during these sessions included the macroeconomic climate, retail media, and the current situation of the open web, among other matters.

Stifel also clarified The Trade Desk’s connection with Walmart, stating that the company “has not lost exclusivity at Walmart and remains the sole DSP provider for Walmart in the U.S.” The Trade Desk’s exclusivity agreement with Walmart only changed in Mexico, according to Stifel’s research report.

The Trade Desk, Inc. (NASDAQ:TTD), a leading supplier of advertising technology, specializes in offering advertising solutions to digital marketers. Advertisers may plan, manage, and optimize their digital ad campaigns across various platforms and channels using its self-service, transparent software and cloud-based platform.

While we acknowledge the potential of TTD to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than TTD and that has 100x upside potential, check out our report about this cheapest AI stock.

READ NEXT: 10 Best Magic Formula Stocks for 2025 and 10 Best Retirement Stocks to Buy According to Hedge Funds.

Disclosure: None. Insider Monkey focuses on uncovering the best investment ideas of hedge funds and insiders. Please subscribe to our free daily e-newsletter to get the latest investment ideas from hedge funds’ investor letters by entering your email address below.

The $250 Trillion AI Hype is Real. A few years from now, you’ll probably wish you’d bought this stock.

Dr. Inan Dogan

Dr. Ian Dogan

Co-Founder and Research Director at Insider Monkey

When Jeff Bezos said that one breakthrough technology would shape Amazon’s destiny, even Wall Street’s biggest analysts were caught off guard.

Fast forward a year and Amazon’s new CEO Andy Jassy described generative AI as a “once-in-a-lifetime” technology that is already being used across Amazon to reinvent customer experiences.

At the 8th Future Investment Initiative conference, Elon Musk predicted that by 2040 there would be at least 10 billion humanoid robots, with each priced between $20,000 and $25,000.

Do the math. According to Musk, this technology could be worth $250 trillion by 2040.

Put another way, that’s roughly equal to:

  • 175 Teslas
  • 107 Amazons
  • 140 Metas
  • 84 Googles
  • 65 Microsofts
  • And 55 Nvidias

And here’s the wild part — this $250 trillion wave isn’t tied to one company, but to an entire ecosystem of AI innovators set to reshape the global economy.

It’s a leap so massive, it could reshape how businesses, governments, and consumers operate worldwide.

Even if that $250 trillion figure sounds ambitious, major firms like PwC and McKinsey still see AI unlocking multi-trillion-dollar potential.

How could anything be worth that much?

The answer lies in a breakthrough so powerful it’s redefining how humanity works, learns, and creates.

And this breakthrough has already set off a frenzy among hedge funds and Wall Street’s top investors.

What most investors don’t realize is that one under-owned company holds the key to this $250 trillion revolution.

In fact, Verge argues this company’s supercheap AI technology should concern rivals.

Before I reveal the details, let’s talk about how some of the richest people on the planet are positioning themselves.

  • Bill Gates sees artificial intelligence as the “biggest technological advance in my lifetime,” more transformative than the internet or personal computer, capable of improving healthcare, education, and addressing climate change.
  • Larry Ellison — through Oracle, is spending billions on Nvidia chips and partnering with Cohere to embed generative AI across Oracle’s cloud and apps.
  • Warren Buffett — not known for tech hype — says this breakthrough could have a ‘hugely beneficial social impact.

When billionaires from Silicon Valley to Wall Street line up behind the same idea — you know it’s worth paying attention to.

Even as we admire what Tesla, Nvidia, Alphabet, and Microsoft have built, we believe an even greater opportunity lies elsewhere…

But the real story isn’t Nvidia — it’s a much smaller company quietly improving the critical technology that makes this entire revolution possible.

And judging by what I’m hearing from both Silicon Valley insiders and Wall Street veterans…

This prediction might not be bold at all:

A few years from now, you’ll wish you’d owned this stock.

The best part? You can discover everything about this company and its groundbreaking technology right now.

I’ve compiled everything you need to know about this groundbreaking company in a detailed, members-only report.

Trust me — you’ll want to read this report before putting another dollar into any tech stock.

For a ridiculously low price of just $9.99 a month, you can unlock a year’s worth of in-depth investment research and exclusive insights – that’s less than a single fast food meal!

Here’s what to do next:

1. Subscribe to our Premium Readership Newsletter for just $9.99 a month. (33% Off – was $14.99).

2. Enjoy a year of ad-free browsing, exclusive access to our in-depth report on the revolutionary AI company, and the upcoming issues of our Premium Readership Newsletter over the next 12 months.

3. Sit back, relax, and know that you’re backed by our ironclad 30-day money-back guarantee.

Don’t miss out on this incredible opportunity! Subscribe now and take control of your AI investment future!

<b>Cancel anytime.</b> Turn off auto-renewal via our website with just a click.

 

Buy This $3 Stock Now Before the 400% Surge Begins

Dr. Inan Dogan

Dr. Ian Dogan

Co-Founder and Research Director at Insider Monkey

My name is Inan Dogan. I’m the co-founder and Research Director of Insider Monkey. I have an important message for you today.

Since March 2017, my stock picks have returned 16.5% annually. Today, I’ve found an opportunity even bigger than my British American Tobacco call.

Two years ago, Wall Street wrote off British American Tobacco (BTI) as a “melting ice cube.” The stock had crashed 40% from its peak, and consensus said the business was dying.

We looked under the cover and realized they were wrong.

We alerted our subscribers, and BTI returned 90% in just 16 months.

Now if you had invested just $10,000 in BTI in June 2024, you’d be sitting on $19,000 in October 2025.

Today, we have identified a nearly identical pattern in a digital-first giant trading at $3.

While the market panics over a surface-level revenue decline, our PhD-led research shows management has actually surgically cut $100 million in waste to focus on high-margin growth.

This pattern is a hallmark of our 16.5% annual return track record. The current opportunity offers a 400% upside potential—dwarfing even our 90% BTI return.

Get the ticker for our new “Underdog” pick and the full BTI case study for just 99 cents.

This exclusive offer is for NEW newsletter subscribers ONLY! Join our Premium Readership Newsletter for only $0.99 and become part of a savvy investor community.!

This offer vanishes in 7 days, so don’t miss your chance to lock in market beating returnsSign up NOW! The monthly newsletter comes with a 30-day, no-risk money-back guarantee. This offer is available to the first 1000 new investors who respond.

Regular price $9.99/mo. Cancel anytime.

Space is Limited! Only 1000 spots are available for this exclusive offer. Don’t let this chance slip away – subscribe to our Premium Readership Newsletter today and unlock the potential for a life-changing investment.

Here’s what to do next:

1. Head over to our website and subscribe to our Premium Readership Newsletter for just $0.99.

2. Enjoy a month of ad-free browsing, exclusive access to our in-depth report on the Trump tariff and nuclear energy company as well as the revolutionary AI-robotics company, and the upcoming issues of our Premium Readership Newsletter.

3. Sit back, relax, and know that you’re backed by our ironclad 30-day money-back guarantee.

Don’t miss out on this incredible opportunity! Subscribe now and take control of your AI investment future!

Regular price $9.99/mo. Cancel anytime.